Screener
Integra LifeSciences IART Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Goodwill | 611,145 | 615,157 |
| Deferred tax assets, net | 70,443 | 69,854 |
| Other assets | 31,591 | 37,880 |
| Total assets | $3,563,490 | $3,602,001 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Current portion of borrowings under senior credit facility | $43,594 | $38,750 |
| Current portion of borrowings under securitization facility | — | 87,800 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's total assets?
- Integra LifeSciences (IART) reported total assets of $3.56B in Q2 2026.
- How has Integra LifeSciences's total assets changed year-over-year?
- Integra LifeSciences's total assets decreased by 2.8% year-over-year, from $3.67B to $3.56B.
- What is the long-term trend for Integra LifeSciences's total assets?
- Over 5 years (2020 to 2025), Integra LifeSciences's total assets has grown at a -0.1% compound annual growth rate (CAGR), from $3.62B to $3.6B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Integra LifeSciences's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude